查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566936

自动免疫检测设备市场：按产品、应用和最终用户分类：2024-2033 年全球机会分析和产业预测

Automatic Immunoassay Analyzer Market By Product , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 228 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，自动免疫检测设备市值为123亿美元，预计2024年至2033年复合年增长率为15.3%，到2033年达到514亿美元。

自动免疫检测设备是利用抗原抗体反应进行免疫检测，对生物检体中的蛋白质、荷尔蒙、药物等物质进行检测和定量的先进医疗设备。自动化从样品製备到结果解释的整个过程，以提高临床和研究环境中的效率、准确性和通量。它广泛应用于诊断实验室、医院和製药业，可提供可靠且一致的结果，提高病患照护和检查结果的速度和品质。

全球自动免疫检测设备市场的成长主要是由癌症、心血管疾病和糖尿病等慢性疾病盛行率的惊人上升所推动的，这些疾病需要频繁且准确的诊断测试。根据世界卫生组织 (WHO) 2023 年 9 月发布的一项研究，心血管疾病是最常见的慢性疾病之一，每年导致 1790 万人死亡，其次是癌症，每年导致约 930 万人死亡。糖尿病，包括因糖尿病导致的肾臟病死亡。此外，不断增加的老年人口对市场成长做出了重大贡献。这是因为，随着人口老化，对监测和管理与老龄化相关的疾病的诊断测试的需求不断增加，从而推动了自动免疫检测设备市场的发展。根据世界卫生组织（WHO）统计，2019年60岁以上人口数达10亿。预计到 2030 年，这一数字将增至 14 亿，到 2050 年将增至 21 亿。随着老年人口的增加，慢性病的发生率预计将显着增加。此外，人们对早期疾病检测和预防性医疗保健重要性的认识不断提高，导致诊断测试的使用增加，从而推动了对自动免疫检测设备的需求。个人化医疗的不断发展趋势需要准确、及时的诊断讯息，这进一步加速了对可靠、高通量免疫检测系统的需求。然而，先进的免疫分析仪需要初始投资和维护成本，以及定期维护、校准和技术支持，限制了市场成长。此外，许多国家缺乏足够的医疗设施来满足人民的需求，而且准入机会有限也是市场的主要阻碍因素。同时，将免疫检测分析仪与数位健康平台和电子健康记录相结合以简化资料管理并提高实验室整体工作流程效率的趋势日益明显，这将有利于预测期内的市场成长。此外，製造商正致力于开发多重免疫测量，可以从单一样本同时测量多种生物标记。这些市场开拓预计将为未来几年的市场成长开闢新的途径。

自动免疫检测设备的全球市场分为产品、应用、最终用户和地区。产品分为萤光、化学冷光、酵素连结萤光系统等。依用途分为感染疾病、内分泌、药物监测、慢性病、过敏检测等。依最终用户分为医院、诊断实验室、製药和生技公司等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲地区。

主要发现

从产品来看，化学冷光领域预计将在 2024 年至 2033 年期间主导市场。

按申请，2023年感染疾病板块为大股东。

从最终用户来看，製药和生物技术公司领域预计未来几年自动化免疫检测设备市场将显着成长。

从地区来看，自动化免疫检测设备在不久的将来可能会在北美引起广泛关注。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章自动免疫检测设备市场：副产品

  • 市场概况
  • 萤光
  • 化学冷光
  • 酵素连结萤光系统
  • 其他的

第五章自动免疫检测设备市场：依应用分类

  • 市场概况
  • 感染疾病
  • 内分泌学
  • 药物监测
  • 慢性疾病
  • 过敏测试
  • 其他的

第六章 自动免疫学测试设备市场：依最终使用者分类

  • 市场概况
  • 医院
  • 诊断实验室
  • 製药和生物技术公司
  • 其他的

第七章自动免疫学测试设备市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国自动化免疫检测设备市场
    • 加拿大自动免疫检测设备市场
    • 墨西哥自动免疫检测设备市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国自动化免疫检测设备市场
    • 法国自动化免疫检测设备市场
    • 英国自动免疫检测设备市场
    • 义大利自动免疫检测设备市场
    • 西班牙自动免疫检测设备市场
    • 其他欧洲国家自动免疫检测设备市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本自动化免疫检测装置市场
    • 中国自动化免疫检测设备市场
    • 印度自动化免疫检测设备市场
    • 澳洲自动免疫检测设备市场
    • 韩国自动免疫检测装置市场
    • 其他亚太地区自动免疫检测设备市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西自动免疫检测设备市场
    • 沙乌地阿拉伯自动免疫检测设备市场
    • 南非自动免疫检测设备市场
    • 其他拉丁美洲/中东/非洲自动免疫检测设备市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Abbott
  • Meril Life Sciences Pvt. Ltd.
  • BioMerieux
  • Arlington Scientific
  • F. Hoffmann-La Roche Ltd
  • Carolina Liquid Chemistries
  • Becton Dickinson And Company,
  • Bio-Rad Laboratories, Inc
  • PerkinElmer Inc.
  • AESKU.GROUP GmbH
简介目录
Product Code: A323969

The automatic immunoassay analyzer market was valued at $12.3 billion in 2023, and is projected to reach $51.4 billion by 2033, growing at a CAGR of 15.3% from 2024 to 2033.

Automatic immunoassay analyzer is an advanced medical device that performs immunoassays using antigen-antibody reactions to detect and quantify substances such as proteins, hormones, and drugs in biological samples. By automating the entire process, from sample preparation to result interpretation, these analyzers enhance efficiency, accuracy, and throughput in clinical and research settings. They are widely used in diagnostic laboratories, hospitals, and pharmaceutical industries to provide reliable and consistent results, thereby improving the speed and quality of patient care and research outcomes.

The growth of the global automatic immunoassay analyzer market is majorly driven by alarming rise in prevalence of chronic conditions such as cancer, cardiovascular diseases, and diabetes, which necessitate frequent and accurate diagnostic testing. According to a study published by the World Health Organization in September 2023, cardiovascular diseases are among the most prevalent most chronic diseases, accounting for 17.9 million deaths annually, followed by cancers with about 9.3 million deaths, and diabetes with 2.0 million deaths, including kidney disease deaths caused by diabetes. Furthermore, surge in geriatric population significantly contributes toward the market growth. This is attributed to the fact that as the population ages, there is an increased demand for diagnostic tests to monitor and manage age-related diseases, thereby boosting the market for automatic immunoassay analyzers. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. With increasing aged population, the incidence of chronic conditions is expected to rise significantly. Moreover, rise in awareness about the importance of early disease detection and preventive healthcare is leading to increased use of diagnostic tests, thus driving the demand for automatic immunoassay analyzers. Increase in trend toward personalized medicine, which requires precise and timely diagnostic information, is further accelerating the demand for reliable and high-throughput immunoassay systems. However, high initial investment and maintenance costs of advanced immunoanalyzers and need for regular maintenance, calibration, and technical support restrain the market growth. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, growing trend toward integrating immunoassay analyzers with digital health platforms and electronic health records to streamline data management and improve the overall efficiency of laboratory workflows is expected to offer lucrative opportunities for the market growth during the forecast period. Furthermore, manufacturers are focusing on developing multiplex immunoassays, which allow the simultaneous measurement of multiple biomarkers from a single sample. Such developments are anticipated to open new avenues for the market growth in the coming years.

The global automatic immunoassay analyzer market is segmented into product, application, end user, and region. On the basis of the product, the market is categorized into immunofluorescence, chemiluminescence, enzyme linked fluorescent system, and others. By application, it is classified into infectious diseases, endocrinology, drug monitoring, chronic diseases, allergy testing, and others. Depending on end user, it is divided into hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the chemiluminescence segment is expected to dominate the market from 2024 to 2033.

On the basis of application, the infectious diseases segment was the major shareholder in 2023.

Depending on end user, the pharmaceutical & biotechnology companies segment is poised for significant growth in the automatic immunoassay analyzer market in the coming years.

Region wise, automatic immunoassay analyzers are likely to gain high prominence in North America in the near future.

Competition Analysis

Competitive analysis and profiles of the major players in the global automatic immunoassay analyzer market include Abbott, Meril Life Sciences Pvt. Ltd., BioMerieux, Arlington Scientific, F. Hoffmann-La Roche Ltd, Carolina Liquid Chemistries, Becton Dickinson and Company,, Bio-Rad Laboratories, Inc, PerkinElmer Inc., and AESKU.GROUP GmbH. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Immunofluorescence
  • Chemiluminescence
  • Enzyme Linked Fluorescent System
  • Others

By Application

  • Infectious Diseases
  • Endocrinology
  • Drug Monitoring
  • Chronic Diseases
  • Allergy Testing
  • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Abbott
    • Meril Life Sciences Pvt. Ltd.
    • BioMerieux
    • Arlington Scientific
    • F. Hoffmann-La Roche Ltd
    • Carolina Liquid Chemistries
    • Becton Dickinson and Company,
    • Bio-Rad Laboratories, Inc
    • PerkinElmer Inc.
    • AESKU.GROUP GmbH

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Immunofluorescence
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Chemiluminescence
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Enzyme Linked Fluorescent System
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Others
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Infectious Diseases
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Endocrinology
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Drug Monitoring
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Chronic Diseases
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Allergy Testing
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country
  • 5.7. Others
    • 5.7.1. Key Market Trends, Growth Factors and Opportunities
    • 5.7.2. Market Size and Forecast, By Region
    • 5.7.3. Market Share Analysis, By Country

CHAPTER 6: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Diagnostic Laboratories
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Pharmaceutical And Biotechnology Companies
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Others
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: AUTOMATIC IMMUNOASSAY ANALYZER MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Automatic Immunoassay Analyzer Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Automatic Immunoassay Analyzer Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Automatic Immunoassay Analyzer Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Automatic Immunoassay Analyzer Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Automatic Immunoassay Analyzer Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Automatic Immunoassay Analyzer Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Automatic Immunoassay Analyzer Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Automatic Immunoassay Analyzer Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Automatic Immunoassay Analyzer Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Automatic Immunoassay Analyzer Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Automatic Immunoassay Analyzer Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Automatic Immunoassay Analyzer Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Automatic Immunoassay Analyzer Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Automatic Immunoassay Analyzer Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Automatic Immunoassay Analyzer Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Automatic Immunoassay Analyzer Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Automatic Immunoassay Analyzer Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Automatic Immunoassay Analyzer Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Automatic Immunoassay Analyzer Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Meril Life Sciences Pvt. Ltd.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. BioMerieux
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Arlington Scientific
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. F. Hoffmann-La Roche Ltd
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Carolina Liquid Chemistries
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Becton Dickinson And Company,
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Bio-Rad Laboratories, Inc
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. PerkinElmer Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. AESKU.GROUP GmbH
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments